Literature DB >> 7714992

Percutaneous aortic stent placement for life threatening aortic rupture due to metastatic germ cell tumor.

P J Terry1, E E Houser, F J Rivera, J C Palmaz, M F Sarosdy.   

Abstract

Patients with testicular carcinoma frequently present with advanced disease and symptoms resulting from metastatic lesions. We report an unusual case of successful emergency management of a massive rupturing aortic pseudoaneurysm midway through systemic chemotherapy for stage III germ cell tumor by percutaneous trans-luminal placement of an aortic bypass stent-graft. Unstable hemorrhage was controlled, allowing our patient to complete chemotherapy and undergo elective retroperitoneal lymph node dissection with resection of the pseudoaneurysm and residual disease after normalization of tumor markers. Final pathological evaluation revealed only fibrosis in the resected tissue. Followup angiography demonstrated a patent stent-graft and the patient was without evidence of disease 1 year after retroperitoneal lymph node dissection.

Entities:  

Mesh:

Year:  1995        PMID: 7714992

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Different sources of reduced carbon contribute to form three classes of terpenoid emitted by Quercus ilex L. leaves.

Authors:  F Loreto; P Ciccioli; E Brancaleoni; A Cecinato; M Frattoni; T D Sharkey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

2.  Surgery for abdominal aortic aneurysms associated with malignancy.

Authors:  S Kurata; K Nawata; S Nawata; H Hongo; R Suto; H Nagashima; Y Kuroda; K Nakayasu; B Shirasawa; K Esato
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

3.  Successful emergency endovascular aortic repair for intratumoral hemorrhage in extensive retroperitoneal mass of testicular origin.

Authors:  S Hulova; R Aziri; I Vulev; P Palacka; G Kolnikova; K Rejlekova; M Chovanec; J Mardiak; D Pindak; M Mego
Journal:  BMC Surg       Date:  2020-11-07       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.